Results 21 to 30 of about 18,389 (235)

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation

Transplantation Direct, 2022
Background. Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, and severe PGD and (2) the safety of ...
Thiru Chinnadurai, MD, Snehal R. Patel, MD, Omar Saeed, MD, Waqas Hanif, MD, Mercedes Rivas-Lasarte, MD, PhD, Muhammad Farooq, MD, Carolyne Castillo, BSN, RN, Maria Taveras, BSN, RN, Daphenie Fauvel, FNP-BC, Jooyoung J. Shin, MD, Daniel Sims, MD, Sandhya Murthy, MD, Sasha Vukelic, MD, PhD, Patricia Chavez, MD, Stephen Forest, MD, Daniel Goldstein, MD, Ulrich P. Jorde, MD   +16 more
doaj   +1 more source

Left ventricular assist device implantation and concomitant aortic valve replacement [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2019
Introduction. The implantable device for mechanical support of the left ventricular circulation (LVAD) is widely applied as a therapeutic option for survival and improvement of the quality of life in patients with the end-stage heart failure.
Mikić Aleksandar, Nestorović Emilija, Bilbija Ilija, Terzić Duško, Putnik Svetozar   +4 more
doaj   +1 more source

Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation

The Egyptian Heart Journal, 2023
Background The left ventricular assist devices (LVADs) are increasingly used for advanced heart failure as a bridge to heart transplantation or as a destination therapy. The aim of this study was to investigate the changes of diastolic pulmonary gradient
Mohamed Laimoud, Emad Hakami, Mary Jane Maghirang, Tahir Mohamed   +3 more
doaj   +1 more source

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device-Associated Pure Aortic Regurgitation. [PDF]

Artif Organs
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hinkov H, Yousefzada S, Just IA, Klein C, Potapov E, Garcia S, Patel D, Ranard LS, Goncharov A, Kereiakes DJ, Makkar RR, Vahl TP, Rudolph TK, Unbehaun A.   +13 more
europepmc   +2 more sources

Surgical treatment of the left ventricular assist device drive line infection with abscess formation [PDF]

Scripta Medica, 2018
Specific left ventricular assist device infections are the leading cause of morbidity and second most common cause of death in patients who survive the first six months after implanting device, and also they are the most common cause of readmissions to ...
Terzic Duško, Nestorović Emilija, Putnik Svetozar, Kačar Saša, Jovičić Vladimir, Janjić Ana, Ristić Miljko   +6 more
doaj  

Left ventricular assist device implantation as bridge to heart transplantation [PDF]

Scripta Medica, 2017
Heart transplantation is a method of choice for the surgical treatment of a terminal stage of cardiac insufficiency. The lack of donors that all health systems in the world are experiencing has led to the intensive development of devices for permanent ...
Terzić Duško, Putnik Svetozar, Nestorović Emilija, Marković Dejan, Ristić Miljko   +4 more
doaj  

A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide

Frontiers in Cardiovascular Medicine, 2022
The use of a left ventricular assist device (LVAD) as a bridge-to-transplantation or destination therapy to support cardiac function in patients with end-stage heart failure (HF) is increasing in all developed countries.
Matteo Cameli, Maria Concetta Pastore, Giulia Elena Mandoli, Federico Landra, Matteo Lisi, Matteo Lisi, Luna Cavigli, Flavio D'Ascenzi, Marta Focardi, Chiara Carrucola, Aleksander Dokollari, Gianluigi Bisleri, Charilaos Tsioulpas, Sonia Bernazzali, Massimo Maccherini, Serafina Valente   +15 more
doaj   +1 more source

Association between early ventricular arrhythmias and mortality in destination vs. bridge patients on continuous flow LVAD support

Scientific Reports, 2021
The association between ventricular arrhythmias (VAs) and mortality in patients supported by continuous flow left ventricular assist devices (LVAD) remains controversial.
Zeina Jedeon, Rebecca Cogswell, Jessica Schultz, Lisa Von Wald, Ranjit John, Henri Roukoz   +5 more
doaj   +1 more source

Patients’ LVAD waveform responses.

, 2020
Patients’ LVAD waveform responses.
Libera Fresiello (4268050), Heinrich Schima (8043344), Christiane Marko (8595759), Christoph Gross (8595750), Dominik Wiedemann (388586), Francesco Moscato (8413617), Martin Maw (8595762), Thomas Schlöglhofer (8595753), Kamen Dimitrov (8595756), Daniel Zimpfer (7900883), Bart Meyns (4268044)   +10 more
core   +1 more source

A Peek at LVADs Pumping to Recovery

Clinical Medicine Insights: Cardiology, 2022
Left ventricular assist devices (LVADs) have revolutionized the management of patients with advanced heart failure refractory to medical therapy. Current indications of LVADs include Bridge to Transplantation (BTT), Destination Therapy (DT) for long-term use, Bridge to the Decision (BTD) used as a temporary measure, and lastly Bridge to Recovery (BTR).
Samiullah Arshad, Rachel D Cutting, Daniel J Stephens, Ythan H Goldberg, Claudius Mahr, Mahender Vyasabattu, Ahmed H Abdelfattah, Gaurang N Vaidya   +7 more
openaire   +3 more sources